Low preoperative skeletal muscle density is predictive for negative postoperative outcomes in older women with ovarian cancer.

Gynecologic Oncology
Vera van der ZandenEsteban T D Souwer

Abstract

To determine the predictive value of lumbar skeletal muscle mass and density for postoperative outcomes in older women with advanced stage ovarian cancer. A multicenter, retrospective cohort study was performed in women ≥ 70 years old receiving surgery for primary, advanced stage ovarian cancer. Skeletal muscle mass and density were assessed in axial CT slices on level L3. Low skeletal muscle mass was defined as skeletal muscle index < 38.50 cm2/m2. Low skeletal muscle density was defined as one standard deviation below the mean (muscle attenuation < 22.55 Hounsfield Units). The primary outcome was any postoperative complication ≤ 30 days after surgery. Secondary outcomes included severe complications, infections, delirium, prolonged hospital stay, discharge destination, discontinuation of adjuvant chemotherapy and mortality. In analysis of 213 patients, preoperative low skeletal muscle density was associated with postoperative complications ≤ 30 days after surgery (Odds Ratio (OR) 2.83; 95% Confidence Interval (CI) 1.41-5.67), severe complications (OR 3.01; 95%CI 1.09-8.33), infectious complications (OR 2.79; 95%CI 1.30-5.99) and discharge to a care facility (OR 3.04; 95%CI 1.16-7.93). Preoperative low skeletal muscle mass was...Continue Reading

References

Oct 1, 1978·Anesthesiology·W D OwensE L Spitznagel
May 18, 2001·Journal of Applied Physiology·B H GoodpasterA B Newman
Sep 21, 1963·JAMA : the Journal of the American Medical Association·S KATZM W JAFFE
Feb 1, 2005·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·H M KruizengaM A E van Bokhorst-de van der Schueren
Jul 30, 2009·Annals of Surgery·Pierre A ClavienMasatoshi Makuuchi
Mar 27, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lisa MartinVickie E Baracos
Feb 6, 2017·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·I J G RuttenT Van Gorp
Jul 25, 2017·Gynecologic Oncology·Amanika KumarWilliam A Cliby
Jul 27, 2017·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Jeroen L A van VugtFrançois E J A Willemsen
Aug 29, 2017·Journal of Geriatric Oncology·Grant R WilliamsShlomit Strulov Shachar
Dec 22, 2017·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Nathália Silva de PaulaGabriela Villaça Chaves
Oct 13, 2018·Age and Ageing·Alfonso J Cruz-JentoftUNKNOWN Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2
Oct 23, 2018·Journal of Geriatric Oncology·Grant R WilliamsShlomit S Shachar
Jan 15, 2019·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·I C van WalreeL H van Huis-Tanja
Aug 8, 2019·Journal of Cachexia, Sarcopenia and Muscle·Jorne UbachsToon Van Gorp
Nov 15, 2019·Clinical Obstetrics and Gynecology·Amanika Kumar, William A Cliby
Jan 4, 2020·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·Esteban Td SouwerJohanna Ea Portielje
Jan 29, 2020·Annals of Oncology : Official Journal of the European Society for Medical Oncology·N ColomboUNKNOWN ESMO-ESGO Ovarian Cancer Consensus Conference Working Group
Apr 4, 2020·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Emanuele RinninellaMaria Cristina Mele
Apr 25, 2020·Journal of Vascular Surgery·Issi R VedderReinoud P H Bokkers
Nov 29, 2020·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Melisa Guelhan InciJalid Sehouli

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.